Literature DB >> 22024272

Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.

Bini Mathew1, Shefali Srivastava, Larry J Ross, William J Suling, E Lucile White, Lisa K Woolhiser, Anne J Lenaerts, Robert C Reynolds.   

Abstract

A series of pyridopyrazine and pyrimidothiazine derivatives have been synthesized and their activity against FtsZ from Mycobacterium tuberculosis (Mtb) and in vitro antibacterial activity against Mtb H(37)Ra and Mtb H(37)Rv are reported. Certain analogs described herein showed moderate to good inhibitory activity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024272      PMCID: PMC3216299          DOI: 10.1016/j.bmc.2011.09.062

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  18 in total

1.  Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics.

Authors:  Jun Wang; Andrew Galgoci; Srinivas Kodali; Kithsiri B Herath; Hiranthi Jayasuriya; Karen Dorso; Francisca Vicente; Antonio González; Doris Cully; David Bramhill; Sheo Singh
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

2.  Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.

Authors:  Danielle N Margalit; Laura Romberg; Rebecca B Mets; Alan M Hebert; Timothy J Mitchison; Marc W Kirschner; Debabrata RayChaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

3.  Synthesis of potential antimalarial agents. II. 6,8-Disubstituted pyrido(2,3-b)pyrazines.

Authors:  C Temple; J D Rose; R D Elliott; J A Montgomery
Journal:  J Med Chem       Date:  1968-11       Impact factor: 7.446

4.  Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.

Authors:  Kunal Kumar; Divya Awasthi; Seung-Yub Lee; Ilaria Zanardi; Bela Ruzsicska; Susan Knudson; Peter J Tonge; Richard A Slayden; Iwao Ojima
Journal:  J Med Chem       Date:  2010-12-02       Impact factor: 7.446

Review 5.  FtsZ, a prokaryotic homolog of tubulin?

Authors:  H P Erickson
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

6.  A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ.

Authors:  R C Reynolds; S Srivastava; L J Ross; W J Suling; E L White
Journal:  Bioorg Med Chem Lett       Date:  2004-06-21       Impact factor: 2.823

7.  Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.

Authors:  C Temple; G A Rener
Journal:  J Med Chem       Date:  1992-12-25       Impact factor: 7.446

8.  Synthesis of potential anticancer agents. Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines.

Authors:  C Temple; G P Wheeler; R N Comber; R D Elliott; J A Montgomery
Journal:  J Med Chem       Date:  1983-11       Impact factor: 7.446

9.  2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.

Authors:  E Lucile White; William J Suling; Larry J Ross; Lainne E Seitz; Robert C Reynolds
Journal:  J Antimicrob Chemother       Date:  2002-07       Impact factor: 5.790

10.  Pyrimidines. 18. 2,4-diamino-5-nitro-6-arylaminopyrimidines. Nitration study of 2,4-diamino-6-chloropyrimidine and a literature correction.

Authors:  D E O'Brien; C C Cheng; W Peleiderer
Journal:  J Med Chem       Date:  1966-07       Impact factor: 7.446

View more
  11 in total

Review 1.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

2.  Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ.

Authors:  Iwao Ojima; Divya Awasthi; Longfei Wei; Krupanandan Haranahalli
Journal:  J Fluor Chem       Date:  2016-07-29       Impact factor: 2.050

Review 3.  Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.

Authors:  Krupanandan Haranahalli; Simon Tong; Iwao Ojima
Journal:  Bioorg Med Chem       Date:  2016-05-05       Impact factor: 3.641

4.  SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents.

Authors:  Divya Awasthi; Kunal Kumar; Susan E Knudson; Richard A Slayden; Iwao Ojima
Journal:  J Med Chem       Date:  2013-11-23       Impact factor: 7.446

5.  Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.

Authors:  Susan E Knudson; Divya Awasthi; Kunal Kumar; Alexandra Carreau; Laurent Goullieux; Sophie Lagrange; Hélène Vermet; Iwao Ojima; Richard A Slayden
Journal:  J Antimicrob Chemother       Date:  2015-08-05       Impact factor: 5.790

6.  A novel quinoline derivative that inhibits mycobacterial FtsZ.

Authors:  Bini Mathew; Larry Ross; Robert C Reynolds
Journal:  Tuberculosis (Edinb)       Date:  2013-05-04       Impact factor: 3.131

7.  Comparison of small molecule inhibitors of the bacterial cell division protein FtsZ and identification of a reliable cross-species inhibitor.

Authors:  David E Anderson; Michelle B Kim; Jared T Moore; Terrence E O'Brien; Nohemy A Sorto; Charles I Grove; Laura L Lackner; James B Ames; Jared T Shaw
Journal:  ACS Chem Biol       Date:  2012-10-05       Impact factor: 5.100

8.  Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.

Authors:  Bini Mathew; Judith Varady Hobrath; Larry Ross; Michele C Connelly; Hava Lofton; Malini Rajagopalan; R Kiplin Guy; Robert C Reynolds
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

9.  Effects of rhodomyrtone on Gram-positive bacterial tubulin homologue FtsZ.

Authors:  Dennapa Saeloh; Michaela Wenzel; Thanyada Rungrotmongkol; Leendert Willem Hamoen; Varomyalin Tipmanee; Supayang Piyawan Voravuthikunchai
Journal:  PeerJ       Date:  2017-02-02       Impact factor: 2.984

10.  A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.

Authors:  Susan E Knudson; Divya Awasthi; Kunal Kumar; Alexandra Carreau; Laurent Goullieux; Sophie Lagrange; Hélèn Vermet; Iwao Ojima; Richard A Slayden
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.